World Asset Management Inc Has $563,000 Position in Qiagen N.V. (QGEN)
World Asset Management Inc reduced its position in shares of Qiagen N.V. (NASDAQ:QGEN) by 0.5% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 16,804 shares of the company’s stock after selling 91 shares during the period. World Asset Management Inc’s holdings in Qiagen N.V. were worth $563,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of QGEN. FNY Managed Accounts LLC acquired a new stake in Qiagen N.V. during the first quarter worth about $103,000. Oppenheimer Asset Management Inc. acquired a new stake in Qiagen N.V. during the first quarter worth about $114,000. Quadrant Capital Group LLC boosted its stake in Qiagen N.V. by 403.4% in the first quarter. Quadrant Capital Group LLC now owns 5,517 shares of the company’s stock worth $154,000 after buying an additional 4,421 shares during the period. Rehmann Capital Advisory Group acquired a new stake in Qiagen N.V. during the first quarter worth about $207,000. Finally, Prudential Financial Inc. acquired a new stake in Qiagen N.V. during the first quarter worth about $207,000. Hedge funds and other institutional investors own 59.84% of the company’s stock.
Shares of Qiagen N.V. (NASDAQ:QGEN) opened at 31.66 on Thursday. The firm has a market capitalization of $7.23 billion, a PE ratio of 96.82 and a beta of 1.14. The stock has a 50 day moving average of $33.60 and a 200-day moving average of $31.14. Qiagen N.V. has a 52 week low of $24.89 and a 52 week high of $35.26.
Qiagen N.V. (NASDAQ:QGEN) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.28 by $0.02. The company had revenue of $349 million during the quarter, compared to the consensus estimate of $353.09 million. Qiagen N.V. had a return on equity of 11.04% and a net margin of 5.44%. The firm’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.24 EPS. Equities analysts anticipate that Qiagen N.V. will post $1.23 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “World Asset Management Inc Has $563,000 Position in Qiagen N.V. (QGEN)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/world-asset-management-inc-has-563000-position-in-qiagen-n-v-qgen/1467863.html.
A number of research firms have issued reports on QGEN. DZ Bank AG reiterated a “neutral” rating on shares of Qiagen N.V. in a research note on Monday, May 29th. Deutsche Bank AG reiterated a “buy” rating on shares of Qiagen N.V. in a research note on Monday, July 31st. Barclays PLC reiterated an “overweight” rating and issued a $37.00 target price (up from $33.00) on shares of Qiagen N.V. in a research note on Monday, July 17th. Commerzbank Ag reiterated a “buy” rating on shares of Qiagen N.V. in a research note on Monday, May 29th. Finally, BidaskClub cut shares of Qiagen N.V. from a “buy” rating to a “hold” rating in a research note on Wednesday, July 5th. Eight equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $33.19.
Qiagen N.V. Company Profile
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials.
Want to see what other hedge funds are holding QGEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Qiagen N.V. (NASDAQ:QGEN).
Receive News & Ratings for Qiagen N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qiagen N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.